Study shows CorPath 200 robotic PCI surgery system (Corindus Inc) is safe and practical

The CorPath 200 robotic system, from Corindus Inc, can safely assist surgeons in performing Percutaneous Coronary Interventions (PCI) while significantly reducing the physician's exposure to radiation and improving precision and control, according to results of the PRECISE study. The CorPath 200 System consists of a robotic drive and single-use cassette mounted on an articulating arm attached to the cath lab patient table. The physician control console located in the shielded interventional cockpit allows the physician to control the PCI devices using simple touch-screen and joystick controls. In the PRECISE study, 164 patients at nine sites were treated with robotically enhanced PCI using the CorPath 200. PCI was successfully completed without having to convert to manual PCI in 98.8 percent of patients, without device-related complications. The overall procedure success rate was 97.6 percent. Physician exposure to radiation was reduced by 95.2 percent. The results of this study will be the basis for a pre-market clearance 510(k) application to the FDA. The results were presented by Giora Weisz, director of Clinical Cardiovascular Research at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital, at the SCAI 2012 Scientific Sessions.